Revolution Medicines, Inc. - RVMD

Sector: Healthcare · Industry: Biological Products, (No Diagnostic Substances)
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$16.49B
QoQ value delta ($000)
+$7.412B (+81.62%)
Implied price effect (QoQ)
+74.94%
Shares
Total shares
201,970,937
QoQ shares delta
+7,425,770 (+3.82%)
Total shares held by funds (by quarter)

Market chart (RVMD)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Manager Value ($000) Shares % of 13F
VANGUARD GROUP INC 1,331,738 16,719,886 0.02%
FARALLON CAPITAL MANAGEMENT LLC 1,161,519 14,582,796 5.48%
JANUS HENDERSON GROUP PLC 980,035 12,303,502 0.44%
BAKER BROS. ADVISORS LP 753,119 9,455,357 4.41%
BlackRock, Inc. 711,008 8,926,656 0.01%
FMR LLC 684,032 8,587,981 0.03%
Nextech Invest, Ltd. 605,426 7,601,087 58.53%
WELLINGTON MANAGEMENT GROUP LLP 556,565 6,987,639 0.1%
Paradigm Biocapital Advisors LP 529,226 6,644,403 13.51%
Park Avenue Institutional Advisers LLC 407,410 5,115 40.5%
Bellevue Group AG 398,705 5,005,719 7.56%
STATE STREET CORP 327,304 4,109,290 0.01%
PRICE T ROWE ASSOCIATES INC /MD/ 271,186 3,404,717 0.03%
BVF INC/IL 267,367 3,356,782 9.0%
Alphabet Inc. 266,437 3,345,102 10.33%
GEODE CAPITAL MANAGEMENT, LLC 251,911 3,161,963 0.02%
UBS Group AG 245,954 3,087,937 0.04%
Logos Global Management LP 238,950 3,000,000 14.44%
DEERFIELD MANAGEMENT COMPANY, L.P. 230,555 2,894,613 2.94%
WESTFIELD CAPITAL MANAGEMENT CO LP 226,605 2,845,013 0.94%
GENERAL ATLANTIC, L.P. 224,049 2,812,928 7.8%
Casdin Capital, LLC 205,284 2,577,333 12.75%
GOLDMAN SACHS GROUP INC 201,799 2,533,583 0.02%
Woodline Partners LP 199,196 2,500,895 0.77%
NORGES BANK 195,568 2,455,347 0.02%